Prenatal Care at 17 Weeks Gestation
At 17 weeks gestation, you should ensure comprehensive prenatal screening is complete, initiate or continue folic acid supplementation (400-800 mcg daily), verify immunization status, screen for gestational diabetes risk factors, and schedule anatomic ultrasound for 18-20 weeks. 1, 2
Essential Components at This Visit
Laboratory Screening (if not already completed)
- Complete blood count to screen for iron deficiency anemia, which increases risks of preterm delivery, intrauterine growth restriction, and perinatal depression 1, 2
- Blood type and Rh status determination - if RhD-negative, plan for Rho(D) immune globulin administration at 28 weeks to prevent alloimmunization 1, 2
- Screening for sexually transmitted infections (syphilis, gonorrhea, chlamydia, HIV, hepatitis B) as these impact pregnancy outcomes 1, 3
- Rubella and varicella immunity testing - if non-immune, plan postpartum vaccination 1, 3
- Urinalysis and urine culture to screen for asymptomatic bacteriuria, which increases preterm delivery risk 1, 2
Genetic Screening and Aneuploidy Testing
- Offer aneuploidy screening (if not completed in first trimester) using quad screen at 15-20 weeks, discussing risks and benefits with all patients 2
- Assess genetic risk based on family history, ethnic background, and maternal/paternal age (≥35 years increases risk of aneuploidy, birth defects, gestational diabetes, hypertension, miscarriage, and stillbirth) 3, 1
- Offer cystic fibrosis carrier screening and other ancestry-based genetic testing as indicated 3, 1
Nutritional Assessment and Supplementation
- Verify folic acid supplementation (400-800 mcg daily) is being taken to reduce neural tube defect risk 1, 2, 3
- Assess body mass index - BMI >25 kg/m² increases risks of gestational diabetes, hypertension, miscarriage, and stillbirth 1
- Screen for nutritional deficiencies including iron status, and treat iron deficiency anemia if present 1, 2
- Counsel on safe food preparation and avoidance of TORCH infections 3
Risk Assessment and Preventive Interventions
High-Risk Screening
- Screen for preeclampsia risk factors including chronic hypertension, prior preeclampsia, diabetes, renal disease, autoimmune disease, or multifetal gestation 1, 4
- If high-risk for preeclampsia, initiate low-dose aspirin (81 mg daily) by 16 weeks (ideally started at 12 weeks) to reduce preeclampsia risk 1, 4, 3
- Screen for gestational diabetes risk factors - if high-risk (obesity, prior gestational diabetes, family history, high-risk ethnicity), perform early glucose testing now rather than waiting until 24-28 weeks 1, 2
Preterm Birth Prevention
- Assess history of prior spontaneous preterm birth - if present in singleton pregnancy, recommend 17-alpha hydroxyprogesterone caproate (17OHP-C) 250 mg intramuscularly weekly starting at 16-20 weeks until 36 weeks 3
- Do not use vaginal progesterone as alternative to 17OHP-C for prior preterm birth prevention, as multiple RCTs show 17OHP-C is superior 3
Immunizations
- Verify influenza vaccination status and administer if not yet received this season 1, 2, 3
- Plan for Tdap vaccination at 27-36 weeks (ideally 27-32 weeks for optimal antibody transfer) 1, 2
- Ensure COVID-19 vaccination is up to date as recommended for all pregnant patients 1
Psychosocial Screening
- Screen for depression and anxiety using validated tools, as mental health issues require timely specialist referral 3, 1, 5
- Screen for intimate partner violence universally, as this impacts pregnancy outcomes 1
- Assess for substance use including tobacco, alcohol, and drugs using CAGE or T-ACE questionnaires 3, 1
- Screen for food insecurity as social determinants of health significantly impact outcomes 1
Medication Review
- Review all prescription and over-the-counter medications for teratogenic potential 3
- Discontinue ACE inhibitors, angiotensin receptor blockers, and statins if still being taken 3
- Counsel on safe medication use during pregnancy 3, 5
Upcoming Milestones
- Schedule anatomic ultrasound at 18-20 weeks for fetal anatomy assessment and detection of structural abnormalities 2
- Plan for gestational diabetes screening at 24-28 weeks using 1-hour glucose challenge test or 2-hour oral glucose tolerance test 1, 2
- Schedule group B streptococcus screening at 36-37 weeks 1, 2
Critical Pitfalls to Avoid
- Do not delay aspirin initiation beyond 16 weeks in high-risk patients, as efficacy decreases with later initiation 1, 4
- Do not substitute vaginal progesterone for 17OHP-C in patients with prior spontaneous preterm birth, as evidence supports 17OHP-C superiority 3
- Do not miss early gestational diabetes screening in high-risk patients by waiting until 24-28 weeks 1, 2
- Do not overlook periodontal disease screening, as treatment decreases preterm delivery risk 1